August 12, 2023 Comments Off on New patent expiration for Boehringer Ingelheim drug TRADJENTA Posted in: Uncategorized
Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are ten patents…
The post New patent expiration for Boehringer Ingelheim drug TRADJE…
August 12, 2023 Comments Off on New patent expiration for Boehringer Ingelheim drug TRIJARDY XR Posted in: Uncategorized
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are sixteen…
The post New patent expiration for Boehringer Ingelheim drug TRIJARD…
